The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Antibiotic perturbations to the gut microbiome
Open accessAbstract
Antibiotic-mediated perturbation of the gut microbiome is associated with numerous infectious and autoimmune diseases of the gastrointestinal tract. Yet, as the gut microbiome is a complex ecological network of microorganisms, the effects of antibiotics can be highly variable. With the advent of multi-omic approaches for systems-level profiling of microbial communities, we are beginning to identify microbiome-intrinsic and microbiome-extrinsic factors that affect microbiome dynamics during antibiotic exposure and subsequent recovery. In this Review, we discuss factors that influence restructuring of the gut microbiome on antibiotic exposure. We present an overview of the currently complex picture of treatment-induced changes to the microbial community and highlight essential considerations for future investigations of antibiotic-specific outcomes. Finally, we provide a synopsis of available strategies to minimize antibiotic-induced damage or to restore the pretreatment architectures of the gut microbial community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Median times to pathogen identification with standard techniques have been reported near 96 h, a critical window during which unnecessary antimicrobial exposure can increase adverse events and the risk of colonization by resistant organisms (3–5).”
From Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy (2026) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“From birth, the gut microbiome works in cohesion with the gut epithelium and surrounding organs to digest and transform nutrients, provide colonization resistance against pathogens and regulate the immune system 2–4 .”
BackgroundGlobal increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
CARD 2020: Antibiotic Resistome Surveillance with the Comprehensive Antibiotic Resistance Database
Alcock, B. P., Raphenya, A. R., Lau, T. T. Y., Tsang, K. K., Bouchard, M., Edalatmand, A., Huynh, W., Nguyen, A.-L. V., Cheng, A. A., Liu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz935 · Cited by 3,202
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Current understanding of the human microbiome
Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“Foundational studies in healthy adult humans have commonly demonstrated the acute decline in alpha diversity 31 (in the first couple of days of treatment) and the incomplete recovery of the microbiome up to 6 months after treatment (often measured by beta diversity between baseline and…”
BackgroundShotgun metagenomics, from sampling to analysis
Quince, C., Walker, A. W., Simpson, J. T., Loman, N. J., & Segata, N. (2017) · Nature Biotechnology · doi:10.1038/nbt.3935 · Cited by 2,202
Cited by
Sorted by citations
Items 101–200 of 440
Relationship Between Human Microbiome and Helicobacter pylori
Placa, G. L., Covino, M., Candeli, M., Gasbarrini, A., Franceschi, F., & Merra, G. (2025) · Microbiology Research · doi:10.3390/microbiolres16010024 · Cited by 10
Schell, L. D., & Carmody, R. N. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.03.009 · Cited by 11
Wang, F., Chen, W., Jia, Y., He, T., Wu, S., Xiang, J., Chen, R., Jiang, Q., Yu, T., Lan, Y., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70994 · Cited by 13
“Conversely, some clinical studies have indicated that post-antibiotic treatment significantly diminishes both the diversity of the microbiome and the abundance of beneficial bacteria in the intestine, which adversely impacts the efficacy of immunotherapy in patients [148, 149].”
Kuang, H., Yang, Y., Luo, H., & Lv, X. (2023) · mSphere · doi:10.1128/msphere.00479-23 · Cited by 11
“The administration pathway and phar macokinetics are important factors that determine the concentration of drugs reach ing the intestine (26).”
BackgroundWang, B., Peng, X., Zhou, X. W., Jin, X., Siddique, A., Yao, J., Zhang, H., Li, Y., Li, Y., & Yue, M. (2024) · eLife · doi:10.7554/elife.101198 · Cited by 11
Zebian, G., Kreitmann, L., Houard, M., Piantoni, A., Piga, G., Aimes, S. R. D., Holik, B., Wallet, F., Labreuche, J., & Nseir, S. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01314-1 · Cited by 12
Melatonin Protects Against Colistin‐Induced Intestinal Inflammation and Microbiota Dysbiosis
Jia, Y., Zhang, T., He, M., Yang, B., Wang, Z., & Liu, Y. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12989 · Cited by 9
Disturbances can facilitate prior invasions more than subsequent invasions in microbial communities
Lear, L., Hesse, E., & Buckling, A. G. J. (2024) · Ecology Letters · doi:10.1111/ele.14493 · Cited by 9
Chen, X., Zheng, A., Li, S., Wang, Z., Chen, Z., Chen, J., Zou, Z., Liang, H., & Liu, G. (2024) · Antioxidants · doi:10.3390/antiox13121550 · Cited by 9
“However, the long-term application of antibiotics has led to several adverse effects, including increased antibiotic resistance, the presence of antibiotic residues in animal products, and environmental pollution [2,3].”
Stepanova, N., Driyanska, V., Korol, L., & Snisar, L. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03935-x · Cited by 9
Wang, X., Yang, Q., Shi, C., Wang, Y., Guo, D., Wan, X., Dong, P., Zhang, Q., Hu, Y., Zhang, R., et al. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf034 · Cited by 9
“The composition and activities of the gut microbiota are affected by a multitude of factors, such as antibiotics [6], surgical treatments [7], diet [8], lifestyle [9], and environmental conditions [10].”
Kim, K., Weiss, A., Ma, H. R., Son, H.-I., Zhou, Z., & You, L. (2025) · Nature Communications · doi:10.1038/s41467-025-57508-z · Cited by 12
“Environmental perturbations, such as temperature 1 – 3 , nutrient 4 , pH 5 – 7 , and antibiotic treatment 8 – 12 , can cause drastic perturbations to microbial community compositions and functionality.”
Zhou, Q., Guo, F., Bian, C., Liu, X., Xiao, X., Hu, R., Lin, J., Wang, W., Lei, H., & Dong, X. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.138529 · Cited by 9
Lavrinienko, A., Greppi, A., Häcki, S., Paramonova, D., & Bokulich, N. A. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105370 · Cited by 11
Huang, Z., Brot, L., Fatouh, R., Bredon, M., Creusot, L., Lefèvre, A., Lamazière, A., Lefevre, J., Emond, P., Planchais, J., et al. (2025) · Gut microbes · doi:10.1080/19490976.2025.2575924 · Cited by 10
Effect of β-lactam antibiotics on the gut microbiota of term neonates
Gu, H., Tao, E., Fan, Y., Long, G., Jia, X., Yuan, T., Chen, L., Shu, X., Zheng, W., & Jiang, M. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00730-2 · Cited by 8
Antibiotic use: impact on the microbiome and cellular therapy outcomes
Darwin, A. H., Xie, J., & Smith, M. M. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024013809 · Cited by 8
Fang, X., Zhang, Y., Huang, X., Miao, R., Zhang, Y., & Tian, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16387 · Cited by 10
“37 Additionally, gut microbiota varies in different anatomical parts of the gastrointestinal tract.”
Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease
Lei, F., Huang, Q., Zhang, C., Lin, Y., Zhang, Y., & Wang, F. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102008 · Cited by 10
Sameeha, F., Riaz, S., Aslam, M., & Perveen, A. (2025) · European journal of medical research · doi:10.1186/s40001-025-03685-y · Cited by 8
Cao, Q., Liu, C., Chen, L., Qin, Y.-H., Wang, T., & Wang, C. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.121632 · Cited by 8
Zhong, B., Liang, W. Y., Zhao, Y., Li, F., Zhao, Z., Gao, Y., Yang, G., & Li, S. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10368-3 · Cited by 11
Yilmaz, G., Chan, M., Lau, C. H., Capitani, S., Kang, M., Charron, P., Hoover, E., Topp, E., & Guan, J. (2024) · Microorganisms · doi:10.3390/microorganisms12112148 · Cited by 7
“Our findings underline the importance of pre-existing gut dysbiosis induced by specific antibiotics on the horizontal transfer of ARGs from food-or water-borne ARB to commensal bacteria, and may help guide antibiotic treatment choices to minimize the dissemination of AMR in the gut microbiome.”
Bacterial microcompartment utilization in the human commensal Escherichia coli Nissle 1917
Clare, C., Rutter, J. W., Fedorec, A. J. H., Frank, S., & Barnes, C. P. (2024) · Journal of Bacteriology · doi:10.1128/jb.00269-24 · Cited by 7
“EcN both directly and indirectly antagonizes multiple enteropathogens through competition and in preventing systemic circulation (11, 12), as well as reducing the invasion capacity of Shiga-like toxin E. coli , Listeria monocytogenes, Salmonella enteritidis, and Legionella pneumophila (13–15).”
Yang, K., Zhao, F., Yang, L., Huang, Y., Shen, L., Liu, H., Feng, Q., & Chen, L. (2024) · Environmental Research Communications · doi:10.1088/2515-7620/ad9e8d · Cited by 6
Zheng, Z.-L., Zheng, Q.-F., Wang, L., & Liu, Y. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i2.100589 · Cited by 9
Tu, T.-T., Yuan, X., Mao, Y.-H., Wang, Y., Chen, Z.-H., Wang, L., Luo, Y., Wang, C., Qiu, S., & Song, A.-X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106340 · Cited by 7
Yin, L.-L., Lv, B., Ge, J., Qi, Y.-K., Xia, J.-Y., Ma, S., Wang, Y., Liu, Y., Zhou, D., Cao, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1566016 · Cited by 7
Rad, S. K., Li, R., Yeo, K. K. L., Cooksley, C. M., Shaghayegh, G., Vreugde, S., Wu, F., Tomita, Y., Price, T. J., Ingman, W. V., et al. (2025) · Cancers · doi:10.3390/cancers17182947 · Cited by 7
“Broad-spectrum antibiotics may impair ICI efficacy by disrupting beneficial microbial–immune interactions [78–81].”
The Gut Resistome Atlas in Preterm Infants Enables Prediction of Necrotizing Enterocolitis Onset
Zeng, S., Wang, H., Zhang, L., Li, S., Yuan, Y., Tian, M., Qu, Y., Ying, J., Zhou, M., Hu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202505154 · Cited by 9
Beyond borders: plasmids drive a shared antibiotic resistome in European urban water systems
He, W., Yu, Z., Wu, Z., Olesen, A. K., Madsen, J. S., Dechesne, A., Smets, B. F., Nesme, J., & Sørensen, S. J. (2026) · Microbiome · doi:10.1186/s40168-025-02253-0 · Cited by 7
“Previous studies have shown that antibiotics have specific effects on the gut microbiome and cause spe - cific microbial perturbation [51], and the gut resistome composition is intimately connected to the taxonomic structure of the gut microbiome [52].”
Xiao, H., Fang, L., Tang, A., Chen, H., Xu, M., Wei, X., Pang, G., & Li, C. (2024) · Immunology · doi:10.1111/imm.13750 · Cited by 7
Whiley, L., Lawler, N. G., Zeng, A. X., Lee, A. J., Chin, S., Bizkarguenaga, M., Bruzzone, C., Embade, N., Wist, J., Holmes, E. C., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00797 · Cited by 8
Recovery of intestinal microbial community in Penaeus vannamei after florfenicol perturbation
Luo, K., Yang, Z., Wen, X., Wang, D., Liu, J., Wang, L., Fan, R., & Tian, X. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136158 · Cited by 7
Zhang, S., Ma, S.-J., Hao, S., Pan, J., Li, Y., Yuan, G., Li, P., Hu, H., & Yu, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141786 · Cited by 9
Han, M., Wang, X., Su, L., Pan, S., Liu, N., Duan, L., Liu, L., Cui, J., Zhao, H., & Yang, F. (2024) · eLife · doi:10.7554/elife.99282 · Cited by 7
“Hence, future studies need to choose wild-type Mtb to establish animal infection models and alveolar macrophages for in vitro experiments to explore the regulation function of Nos2 expression on NO, ROS, and Defb1, which will resolve these limitations of the study.”
BackgroundSuvvari, T. K., Vallurupalli, V., Koneru, K. S., Ingawale, S., & Yegurla, R. R. (2025) · Cureus · doi:10.7759/cureus.84114 · Cited by 12
Exploring the memory of the gut microbiome: a multifaceted perspective
Zorgani, A., & Das, B. C. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1363961 · Cited by 5
Cuisiniere, T., & Santos, M. M. (2024) · F1000Research · doi:10.12688/f1000research.151662.1 · Cited by 6
Metagenomic changes in response to antibiotic treatment in severe orthopedic trauma patients
Kouraki, A., Zheng, A. S., Miller, S., Kelly, A., Ashraf, W., Bazzani, D., Bonadiman, A., Tonidandel, G., Bolzan, M., Vijay, A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110783 · Cited by 6
Intratumoral microbiota as cancer therapeutic target
Guo, C., An, Q., Zhang, L., Wei, X., Xu, J., Yu, J., Wu, G., & Ma, J. (2024) · Aging Medicine · doi:10.1002/agm2.12359 · Cited by 7
Gao, W., Wang, G., Yuan, H., Chen, Y., Che, J., Cheng, Z., Chen, L., Zhang, L., Zhu, Y., Liu, X., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01370-5 · Cited by 6
“…disease, Wilson’s disease, alpha 1-antitrypsin deficiency, Budd-Chiari syndrome, and other congenital liver diseases; (4) combined with severe organic lesions; (5) pregnant and lactating women; (6) no antibiotics or proton pump inhibitors which affected gut microbiota in the past 1 month [15, 16].”
The microbiota, the malarial parasite, and the mice—a three-sided relationship
He, S., & Qi, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1615846 · Cited by 7
State of omics-based microbial diagnostics of CRC
Prusa, J., Gorelik, M. G., Blake, K. S., & Dantas, G. A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2526132 · Cited by 6
“155–161 Despite the growing understanding of these covariates and their importance to inter-individual microbiome variance, studies attempting to attribute micro-biome signatures to pathologies rarely control for these confounding variables leaving open the possibility that the associations…”
Self-citationGeographic diversity in inflammatory bowel disease genetics and microbiome
Hao, F., Zhu, W., Zheng, J., Ng, S. C., & Zhang, J. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.06.017 · Cited by 7
A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics
Zhang, Q., Yang, Y., Yang, Y., Shang, J., Su, S., Gao, P., Li, X., Liu, Z., Kao, R. Y. T., Ko, B. C. B., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105914 · Cited by 6
Du, D., Yuan, Y., Guan, X., Xie, Q., Sun, X., & Dong, Z. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561222 · Cited by 7
“The use of antibiotics, particularly broad-spectrum ones, is associated with reduced alpha diversity and incomplete recovery of the microbiome in adults [28].”
Studying low-dose antibiotic effects on the gut microbiome
Bourdin, T., Páez, L. C. C., Massard, M., & Hocquet, D. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.11.014 · Cited by 7
The gut as a central hub for multi-organ crosstalk in aging
Zhang, X., Li, R., Gao, Y., Zhang, W., Ni, T., & Liu, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06129-w · Cited by 7
Systematic review: effect of probiotics on antibiotic-induced microbiome disruption
Łukasik, J., Dierikx, T. H., Johnston, B. C., de Meij, T. G. J., & Szajewska, H. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00023 · Cited by 10
Antibiotics’ collateral effects on the gut microbiota in the selection of ESKAPE pathogens
Flury, B. B., Andrey, D. O., & Kohler, P. P. (2024) · CMI Communications · doi:10.1016/j.cmicom.2024.100012 · Cited by 7
Lee, E., Lee, G.-Y., Hossain, M. A., Awji, E. G., & Park, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-69566-2 · Cited by 7
Akhmedov, M., & Espinoza, J. L. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101229 · Cited by 6
Dynamics of antibiotic resistance genes and bacterial community structure within substrate biofilms
Li, Y., Liu, K., Qiu, H., Chen, F., Zhang, J., & Zheng, Z. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.123512 · Cited by 6
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 7
Newson, J. P. M., McHugh, S. C., Steiger, Y., Gürtler, F., Bakkeren, E., & Hardt, W. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115969 · Cited by 6
Understanding the Relationship Between Cerebrovascular Disease and the Gut Microbiome
Roth, W., Lo, E., DeLeon, O., Suriya, S. S., Fakhri, F., Brorson, J. R., Polster, S. P., Kass‐Hout, T., Prabhakaran, S., & Siegler, J. E. (2024) · Stroke Vascular and Interventional Neurology · doi:10.1161/svin.124.001272 · Cited by 7
“98 With a growing awareness of commensal microbiota, there is an increasing emphasis on stewardship with targeted antibiotics to avoid detrimental effects related to losses of beneficial microorganisms.”
Sarangarajan, A. V., Jain, A., Ferreir, J. L., Anushree, Dhanawat, A., Ahir, P., & Acharya, S. R. (2024) · PharmaNutrition · doi:10.1016/j.phanu.2024.100402 · Cited by 5
Dai, J., Wang, W., He, F., Wang, Y., & Zou, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1459668 · Cited by 7
“It was able to reduce the Firmicutes/Bacteroidetes (F/B) ratio (Zhao et al., 2020; Wolter et al., 2021; Fishbein et al., 2023), leading to an alleviation of Frontiers in Pharmacology frontiersin.org 09 Dai et al. 10.3389/fphar.2025.1459668 colitis.”
InfluentialEmerging Contaminants: An Important But Ignored Risk Factor for Psoriasis
Huang, L., Zhou, Y. Y., Xiao, H., Li, Y., Zhou, Z., Xiao, Z., Tong, Y., Hu, K., Kuang, Y., Shen, M., et al. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09043-4 · Cited by 5
“Both skin microbes and gut microbes play a role in psoriasis, and antibiotics have a huge impact on the microflora [59–62].”
Zhang, P., Liu, Y., Xu, M., Zhang, J., Xia, J., Shi, Y., Wang, J., Han, B., & Feng, G. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111200 · Cited by 5
“Exposure to various antibiotics typically induces significant alterations in microbial community structure, species composition, and metabolic capacity [34].”
Văruț, R. M., Ciolofan, M. S., Veronica, M. E., Radivojević, K., Trașcă, D.-M., Popescu, C., Diaconu, O. A., & Singer, C. E. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060752 · Cited by 6
“These agents may reduce species richness, alter metabolic pathways, and foster the proliferation of antibiotic-resistant strains, thereby increasing the risk of complications such as antibiotic-associated diarrhea or Clostridioides difficile infection [61].”
Marsaux, B., d’Hoker, W., Moens, F., Elst, D. V., Minnebo, Y., Marzorati, M., & de Wiele, T. V. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00803-w · Cited by 5
Wang, M., Liu, X., Wang, J., Hao, S., & Sun, X. (2025) · Journal of Environmental Management · doi:10.1016/j.jenvman.2025.127514 · Cited by 5
Xie, Y., Wang, J., Han, Y., Zhu, G., Li, C., Sun, Q.-Q., & Li, C. (2025) · Advanced Materials · doi:10.1002/adma.202515904 · Cited by 5
Li, L., Zhu, J., Yan, Y., Li, Z., & Du, H. (2026) · Microorganisms · doi:10.3390/microorganisms14030634 · Cited by 6
From gut dysbiosis to eubiosis: understanding microbiome recovery as an ecological process
Kennedy, M. S., & Chang, E. B. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2649448 · Cited by 5
Neglected positive role of inactivating antibiotic resistance genes in the environment
Zhang, L., Cui, H., Li, Q., Shi, K., Gao, S.-H., Larsson, D. G. J., Wang, A., & Liang, B. (2026) · Nature Water · doi:10.1038/s44221-026-00640-x · Cited by 5
“…approaches: an extracellular heterodimeric β-lactamase expressed by Lactococcus lactis has been found to preserve gut microbiota integrity during treatment by lowering intraluminal antibiotic exposure, limiting resistance emergence, maintaining diversity, and reducing pathogen overgrowth 70,71 .”
Zhao, M., Cao, L., Bai, Q., Lu, Y., Li, B., Wu, W., Ye, J.-Z., Chen, X., Wang, Z., Liu, B., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202408918 · Cited by 5
Han, M., Wang, X., Su, L., Pan, S., Liu, N., Duan, L., Liu, L., Cui, J., Zhao, H., & Yang, F. (2024) · eLife · doi:10.7554/elife.99282.3 · Cited by 5
Winters, A. D., Francescutti, D. M., Kracht, D. J., Chaudhari, D. S., Zagorac, B., & Angoa‐Pérez, M. (2025) · Microorganisms · doi:10.3390/microorganisms13010077 · Cited by 5
Bisubstrate Analog Inhibitors of DXP Synthase Show Species Specificity
Henriquez, S., Nosal, C. R., Knoff, J. R., Coco, L. B., & Meyers, C. L. F. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00549 · Cited by 5
Ma, Z., Wen, X., Zhang, Y., Ai, Z., Zhao, X., Dong, N., Dou, X., & Shan, A. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c10406 · Cited by 5
Wang, B., Peng, X., Zhou, X., Jin, X., Siddique, A., Yao, J., Zhang, H., Li, W., Li, Y., & Yue, M. (2025) · eLife · doi:10.7554/elife.101198.4 · Cited by 5
Kong, J., Yang, F., Zong, Y., Wang, M., Jiang, S., Ma, Z., Li, Z., Li, W., Cai, Y., Zhang, H., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111449 · Cited by 6
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway?
Abenavoli, L., Scarlata, G. G. M., Scarpellini, E., Procopio, A. C., Ponziani, F. R., Boccuto, L., Ćetković, N. B., & Luzza, F. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.23.03590-8 · Cited by 5
An, R., Zhou, X., He, P., Lyu, C., & Wang, D. (2024) · Food & Function · doi:10.1039/d3fo05186b · Cited by 5
Reveles, K. R., Gonzales-Luna, A. J., Golan, Y., Alonso, C. D., Guthmueller, B., Tan, X., Bidell, M. R., Pokhilko, V., Crawford, C. V., & Skinner, A. M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae341 · Cited by 5
“Factors that can affect gut microbiota dysbiosis after antibiotic exposure include the spectrum of antibiotic activity (eg, anaerobic), pharmacokinetics (eg, biliary elimination rate), total dose, and duration of treatment [24].”
BackgroundLongitudinal changes in bifidobacterial population during the first two years of life
An, R., Fontana, F., Daele, E. V., Ventura, M., Vlieger, A. M., van Elburg, R. M., Knol, J., Milani, C., & Belzer, C. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00012 · Cited by 4
The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications
Merra, G., Placa, G. L., Covino, M., Candelli, M., Gasbarrini, A., & Franceschi, F. (2025) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2501273 · Cited by 6
McMahon, S., Franklin, S., & Galloway-Peña, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1629422 · Cited by 7
“Rather than signaling a harmful shift, the presence of these genes might re fl ect a microbiome that ’ s been shaped by past antibiotic exposure but remains functionally resilient (Bhattarai et al., 2024; Fishbein et al., 2023).”
Antibiotics in Animal Feeds: Benefits and Risks
Rasool, F., Parveen, S., Manzoor, K., Mahmood, S., & Ayub, A. (2025) · Veterinary medicine and science · doi:10.5772/intechopen.1009998 · Cited by 4
Li, Y., Xu, X., Peng, C., Liu, Y., Lü, N., Zhu, Y., & He, C. (2025) · mSystems · doi:10.1128/msystems.01090-25 · Cited by 4
Wang, X., Wang, Y., Guo, C., Guo, R., Zuo, W., Liu, C., Wang, J., Gao, C., Zhang, L., Yuan, W., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123772 · Cited by 4
Antibiotic Exposure and Cardiovascular Disease Risk: A Nationwide Cohort Study
Park, S. J., Kim, M., Jeong, S., Choi, S., Kim, H. J., Kim, H. J., Song, J., Lee, J., Lee, J., Lee, J. W., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.035888 · Cited by 4
“28,29 Several trials assessing antibiotics for secondary cardiovascular prevention yielded largely null results and, in some cases, suggested potential adverse effects.”
Hasan, M. I., Smyth, D. S., & Teufel, A. I. (2025) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaf147 · Cited by 4
“Previous research has applied these approaches to the study of multidrug susceptibility in other pathogens, various diseases, and other complex disorders [ 23 , 2 24 ].”
Xu, H., Yu, Y., Ye, T., Miao, L., Zhou, B., Sun, P., & Dong, X. (2026) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2026.121030 · Cited by 4
Community protection of antibiotic biodegradation modulates microbiome succession and stability
Zhang, L., Qian, L. I., Yi, G., Cui, H., Liu, Y., Shi, K., Wang, B., Wang, A.-J., & Liang, B. (2025) · Biocontaminant · doi:10.48130/biocontam-0025-0016 · Cited by 5
Innovative mitochondria-based holistic 3PM approach to female health status: Facts and outlook
Pešta, M., Goncharenko, V., Kulda, V., Polívka, J., Rizaev, J., & Golubnitschaja, O. (2026) · The EPMA Journal · doi:10.1007/s13167-026-00438-7 · Cited by 5
“The extent of disruption depends on factors such as the type, duration, and spectrum of antibiotics used, as well as individual host factors like age, diet, and underlying health conditions [135, 137, 138].”
Gut microbiota and sepsis: mechanisms, clinical correlations, and therapeutic prospects
Yu, J., & Liu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1793041 · Cited by 4
“Interactions with diet and host metabolites further alter the susceptibility and recovery capacity of the microbiota to antibiotics (29), and dierent antibiotics exert specific eects on the microbiota.”
Shen, H., Zhang, L., Ma, X., Yin, Y., Wang, J., & Tan, B. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3163-6 · Cited by 5
“…by microbial interactions, such as enhanced root nutrient uptake under stress (Bandyopadhyay et al., 2022; Bilder et al., 2009; Busemeyer et al., 2013; Fishbein et al., 2023; Gosa et al., 2019; Priya et al., 2023; Salvi et al., 2022; Tardieu et al., 2017; Tuggle et al., 2022; Verma et al., 2021).”
Liu, L., Kang, P.-T., Ding, F.-Y., Shao, D.-H., Wang, B.-S., Yang, J., Gao, W., Zhang, W., Wang, W., & Liu, J.-X. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742238 · Cited by 4
Gu, B., Jung, H. Y., Rim, C., Kim, T., Lee, S., Choi, D. Y., Park, H., & Kim, M. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70173 · Cited by 4
“Antibiotic treatment is commonly used in FMT research to deplete gut microbiota in recipient animals, as it provides an easy method to overcome colonisation resistance (Kennedy et al. 2018; Tan et al. 2022; Fishbein et al. 2023).”
Wenjiao, D., Yurou, W., Jiaqi, X., Yan, H., Ji, H., Min, C., & Jianjin, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1508473 · Cited by 4
Xu, J., Wen, X., Wang, S., Worrich, A., Ma, B., Zou, Y., Wang, Y., & Wu, Y. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139638 · Cited by 4
Gut microbiome disruption in free-roaming cats: Do antibiotics reduce or restructure zoonotic risk?
Xie, A., Zhang, Y., Tang, Z., Robinson, J. M., Huang, Q., Su, J., & Sun, X. (2025) · One Health · doi:10.1016/j.onehlt.2025.101186 · Cited by 4
“Beyond targeting pathogenic bacteria, antibiotics often disrupt commensal taxa, leading to marked alterations in microbiome composition and reductions in overall diversity [13].”
Stinson, L. F., Pang, W. W., Rea, A., Fok, D., Chua, M. C., Tan, K. H., Yap, F. K. P., Godfrey, K. M., Shek, L. P., Eriksson, J. G., et al. (2025) · mSystems · doi:10.1128/msystems.00677-25 · Cited by 5
“Antibiotics are powerful disruptors of the human microbiome (70, 71).”
Gut bacterial dysbiosis in pediatric severe malaria associates with post-discharge mortality
Bednarski, O. J., Lehman, S. M., Mzinza, D. T., Kazinga, C., Namazzi, R., Opoka, R. O., Ren, J., Tran, T. M., Taylor, T. E., Seydel, K. B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64632-3 · Cited by 4
Thavamani, A., Sankararaman, S., Al-Shakhshir, H., Retuerto, M., Velayuthan, S., Sferra, T. J., & Ghannoum, M. A. (2023) · Antibiotics · doi:10.3390/antibiotics12111606 · Cited by 6
“The impact of antibiotics on the gut microbiome is complex and variable, based on multiple factors such as patient characteristics and antibiotic details [43].”
BackgroundGut microbiota: a potential influencer of insomnia occurring after COVID-19 infection
Fang, J., Wang, S., Liu, L., Zhang, X., Liu, R., Pang, X., Cui, J., Han, J., & Zhu, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1423715 · Cited by 4
“Antibiotics eliminate pathogenic bacteria in the gut while destroying bene fi cial fl ora, thus affecting the ecological niches of microorganisms responsible for metabolic transformation in the gut wall (74).”
Metadata
- Authors
- Fishbein, S. R. S., Mahmud, B., & Dantas, G.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Dantas, Gautam
- Venue
- Nature Reviews Microbiology
- Published
- 2023-07-25
- Volume
- 21
- Issue
- 12
- Pages
- 772-788
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC12087466
- OpenAlex
- W4385240643
- Cited by
- 440
- References
- 229
- Citations by year
- 2026: 152 · 2025: 165 · 2024: 115 · 2023: 7
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- Centers for Disease Control and Prevention (R01OH011578)
- Agency for Healthcare Research and Quality (R01 HS027621)
- National Institute of Allergy and Infectious Diseases (U01AI123394, R01AI155893)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK077653)
- National Institute for Occupational Safety and Health (R01 OH011578)
- National Center for Complementary and Integrative Health (R01AT009741)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD092414)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
- Keywords
- gut microbiota, antibiotics, microbiome perturbation, microbiome recovery, gastrointestinal diseases, autoimmune disease, multi-omics profiling
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Gastrointestinal Tract, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review